Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 109

Sort by

Sort Order Select

Journal Articles

Targeting nucleotide metabolism to enhance ara-c sensitivity in myeloid leukemia associated with down syndrome

Jenna Thibodeau, Holly Edwards, Lisa Polin, Juiwanna Kushner, Sijana Dzinic, Kathryn White, Xun Bao, Jing Li, Jeffrey Taub, Yubin Ge

Blood (2025) 146 (Supplement 1): 1505.

https://doi.org/10.1182/blood-2025-1505

Published: 2025

Journal Articles

Impact of hereditary predisposition genes to hematologic malignancies on transplant outcomes and donor selection

Zhihui Li, Qinlong Zheng, Keyan Yang, Xianxuan Wang, Jing Li, Qian Fei, Jiahong Zhai, Zongyang Ming, lei wang, Xiaopei Wen, Yanzhi Song, Yongqiang Zhao, Tong Wu

Blood (2025) 146 (Supplement 1): 1053.

https://doi.org/10.1182/blood-2025-1053

Published: 2025

Journal Articles

Real-world outcomes of glofitamab-based regimens in relapsed/refractory aggressive B-cell lymphoma

Yuhong Ren, Yang Ke, Zhixiang Cheng, Ling Yuan, Weiguang Wang, Jingli Zhuang, Luya Cheng, Yue Wang, Jiadai Xu, Xuejiao Zhang, Jing Li, Peng Liu

Blood (2025) 146 (Supplement 1): 7257.

https://doi.org/10.1182/blood-2025-7257

Published: 2025

Journal Articles

All-trans retinoic acid mitigates IL-1β-driven NEU1-mediated megakaryocyte desialylation and dysfunction in immune thrombocytopenia

Peng Zhao, Jing-Li Han, Hai-Xia Fu, Zhuo-Yu An, Yue Jin, Lan-Ping Xu, Xiaojun Huang, Xiaohui Zhang

Blood (2025) 146 (Supplement 1): 1243.

https://doi.org/10.1182/blood-2025-1243

Published: 2025

Journal Articles

Boosting anti-tumor immunity in NRAS;ASXL1-driven Acute Myeloid Leukemia through combined inhibition of MEK and HDACs.

Meher Gayatri Bolisetti, Anthony Veltri, Jacqueline Cook, Bei Jia, Jing Li, Maoshou Yang, Vysakh Anandan, Jiacheng Yao, Kenneth Man Chan, Sarah Granozio, Esraa Keewan, Erik Ranheim, Xiaolan Zhu, Kalyan Nadiminti, Suresh Marulasiddappa, Hong Zheng, Xiaona You, Jing Zhang

Blood (2025) 146 (Supplement 1): 5007.

https://doi.org/10.1182/blood-2025-5007

Published: 2025

Journal Articles

CDCP1+ mesenchymal stem cells preferentially inhibit acute graft-versus-host disease(aGVHD)

Lun Yan, Jing Li, Xi Zhang, Cheng Zhang

Blood (2025) 146 (Supplement 1): 2466.

https://doi.org/10.1182/blood-2025-2466

Published: 2025

Journal Articles

Initial Results of the first-in-human Phase 1 study of IBI3003, a novel trispecific antibody targeting GPRC5D, BCMA and CD3, in patients with relapsed or refractory multiple myeloma

Jing Li, Zhenyu Li, Chunrui Li, Pengcheng He, Jun Luo, Rong Fu, Liye Zhong, Hang Quach, Jay Hocking, Peter Presgrave, Xiaoyi Tang, Wen Zhang, Jinchao Gao, Luyin Ding, Peiqi Li, Hui Zhou, Peng Liu

Blood (2025) 146 (Supplement 1): 702.

https://doi.org/10.1182/blood-2025-702

Published: 2025

Journal Articles

Paquinimod regulate megakaryocyte function by restoring mitochondrial oxidative phosphorylation in acute myeloid leukemia

Meng-Yu Xiao, Jing-Li Han, Jian-Ying Zhou, Menglin Li, Yuxiu Chen, Mengtong Zang, Lu-Lu Wang, Qiuyu Guo, Xiaohui Zhang

Blood (2025) 146 (Supplement 1): 3021.

https://doi.org/10.1182/blood-2025-3021

Published: 2025

Journal Articles

An exploratory study to evaluate the safety and efficacy of autologous CAR-T cells with dual targeting of BCMA and CD19 (FKC289 Injection) in subjects with relapsed or refractory systemic light chain amyloidosis

Jing Li, Shiyang Gu, Yuhong Ren, Yang Yang, Jiadai Xu, Yian Zhang, Tianhong Xu, Xiaochen Wang, Xiaojiao Zhao, He Xin, Zisong Zhou, Peng Liu

Blood (2025) 146 (Supplement 1): 7674.

https://doi.org/10.1182/blood-2025-7674

Published: 2025

Journal Articles

Interleukin-8 inhibition by reparixin protects megakaryocytes and alleviates thrombocytopenia in Acute Myeloid Leukemia

Jing-Li Han, Meng-Yu Xiao, Jian-Ying Zhou, Ting Wang, Xiaolu Zhu, Hai-Xia Fu, Qian Jiang, Lan-Ping Xu, Xiaojun Huang, Xiaohui Zhang

Blood (2025) 146 (Supplement 1): 3235.

https://doi.org/10.1182/blood-2025-3235

Published: 2025

Journal Articles

Phase 2 Study of polatuzumab vedotin, zanubrutinib and rituximab (Pola-ZR) in untreated elderly and frail DLBCL patients: Molecular features and follow-up updates

Yuhong Ren, Jing Li, Zhixiang Cheng, Jingli Zhuang, Hui Tan, Luya Cheng, Ling Yuan, Yang Ke, Peng Liu

Blood (2025) 146 (Supplement 1): 1917.

https://doi.org/10.1182/blood-2025-1917

Published: 2025

Journal Articles

Epidemiology, clinical features, and molecular basis of TTMV :: RARA -driven acute promyelocytic leukemia

Blood (2025) 146 (18): 2229–2243.

https://doi.org/10.1182/blood.2025028674

Published: 2025

Includes: Supplemental data

Journal Articles

A phase 1 trial of prizloncabtagene autoleucel, a CD19/CD20 CAR T-cell therapy for relapsed/refractory B-cell non-Hodgkin lymphoma

Blood (2025) 145 (14): 1526–1535.

https://doi.org/10.1182/blood.2024026401

Published: 2025

Includes: Supplemental data

Journal Articles

Influence of Somatic and Germline Gene Variants on the Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Hematological Malignancies

Zhihui Li, Keyan Yang, Lei Wang, Xianxuan Wang, Xiaopei Wen, Jingjing Wang, Jing Li, Yanzhi Song, Yongqiang Zhao, Qinlong Zheng, Tong Wu

Blood (2024) 144 (Supplement 1): 4922.

https://doi.org/10.1182/blood-2024-200716

Published: 2024

Journal Articles

Tandem CAR-T-Cell Therapy Targeting CD5 and CD7: Facilitating Condition-Free Engraftment of Epitope-Edited Allogeneic HSCs

Guo-Ling Wang, Ting Wang, Jing-Li Han, Li-Xin Wu, Xuan-Zhong Chen, Zhuo-Yu An, Chen-Cong Wang, Peng Zhao, Lu-Lu Wang, Meng-Tong Zang, Wei Zheng, Hai-Xia Fu, Jia Feng, Hong-Yu Zhang, Xiaohui Zhang

Blood (2024) 144 (Supplement 1): 2041.

https://doi.org/10.1182/blood-2024-208043

Published: 2024

Journal Articles

Differentiation Route Generates Functional Biased Platelets and Responses Distinctly to Varying Physiological Demands

Jingkun Liu, Liping Wang, Yanxun Su, Kunying Chen, Jing-Jing Li, Bo O. Zhou, Yueying Li, Qian-Fei Wang

Blood (2024) 144 (Supplement 1): 426.

https://doi.org/10.1182/blood-2024-204569

Published: 2024

Journal Articles

IL-2-Inducible T Cell Kinase Deficiency Enables Development of Sustainable Chimeric Antigen Receptor T Cell Therapy

Blood (2024) 144 (Supplement 1): 3411.

https://doi.org/10.1182/blood-2024-201942

Published: 2024

Journal Articles

Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation Improved Prognosis for Advanced NK/T Cell Lymphoma

Zhihui Li, Xianxuan Wang, Keyan Yang, Lei Wang, Xiaopei Wen, Jingjing Wang, Jing Li, Yanzhi Song, Yongqiang Zhao, Qinlong Zheng, Tong Wu

Blood (2024) 144 (Supplement 1): 599.

https://doi.org/10.1182/blood-2024-200684

Published: 2024

Journal Articles

Comparison of Ixazomib, Lenalidomide Plus Dexamethasone (IRd) and Bortezomib, Lenalidomide Plus Dexamethasone (VRd) in Newly Diagnosed Multiple Myeloma in China

Wenjing Wang, Jing Li, Mengyuan Li, Xiao He, LI Bao, Xiaoqiong Tang, Hua Xue, Jianmei Xu, Liye Zhong, Peng Liu

Blood (2024) 144 (Supplement 1): 5159.

https://doi.org/10.1182/blood-2024-207888

Published: 2024

Journal Articles

Assessing Cytogenetic Abnormalities in Myeloma: A Comparative Study of Hi-C, Karyotyping, and iFISH Techniques

Jing Li, Yang Yang, Chenqi Yu, Yuxia Yang, Peng Liu

Blood (2024) 144 (Supplement 1): 4700.

https://doi.org/10.1182/blood-2024-207188

Published: 2024

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Targeting nucleotide metabolism to enhance ara-c sensitivity in myeloid leukemia associated with down syndrome

Impact of hereditary predisposition genes to hematologic malignancies on transplant outcomes and donor selection

Real-world outcomes of glofitamab-based regimens in relapsed/refractory aggressive B-cell lymphoma

All-trans retinoic acid mitigates IL-1β-driven NEU1-mediated megakaryocyte desialylation and dysfunction in immune thrombocytopenia

Boosting anti-tumor immunity in NRAS;ASXL1-driven Acute Myeloid Leukemia through combined inhibition of MEK and HDACs.

CDCP1+ mesenchymal stem cells preferentially inhibit acute graft-versus-host disease(aGVHD)

Initial Results of the first-in-human Phase 1 study of IBI3003, a novel trispecific antibody targeting GPRC5D, BCMA and CD3, in patients with relapsed or refractory multiple myeloma

Paquinimod regulate megakaryocyte function by restoring mitochondrial oxidative phosphorylation in acute myeloid leukemia

An exploratory study to evaluate the safety and efficacy of autologous CAR-T cells with dual targeting of BCMA and CD19 (FKC289 Injection) in subjects with relapsed or refractory systemic light chain amyloidosis

Interleukin-8 inhibition by reparixin protects megakaryocytes and alleviates thrombocytopenia in Acute Myeloid Leukemia

Phase 2 Study of polatuzumab vedotin, zanubrutinib and rituximab (Pola-ZR) in untreated elderly and frail DLBCL patients: Molecular features and follow-up updates

Epidemiology, clinical features, and molecular basis of TTMV :: RARA -driven acute promyelocytic leukemia

A phase 1 trial of prizloncabtagene autoleucel, a CD19/CD20 CAR T-cell therapy for relapsed/refractory B-cell non-Hodgkin lymphoma

Influence of Somatic and Germline Gene Variants on the Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Hematological Malignancies

Tandem CAR-T-Cell Therapy Targeting CD5 and CD7: Facilitating Condition-Free Engraftment of Epitope-Edited Allogeneic HSCs

Differentiation Route Generates Functional Biased Platelets and Responses Distinctly to Varying Physiological Demands

IL-2-Inducible T Cell Kinase Deficiency Enables Development of Sustainable Chimeric Antigen Receptor T Cell Therapy

Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation Improved Prognosis for Advanced NK/T Cell Lymphoma

Comparison of Ixazomib, Lenalidomide Plus Dexamethasone (IRd) and Bortezomib, Lenalidomide Plus Dexamethasone (VRd) in Newly Diagnosed Multiple Myeloma in China

Assessing Cytogenetic Abnormalities in Myeloma: A Comparative Study of Hi-C, Karyotyping, and iFISH Techniques

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only